Rockefeller Capital Management
LENZ

Rockefeller Capital Management’s LENZ Therapeutics LENZ Stock Holding History

Rockefeller Capital Management’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$525K Buy
92,350
+19,010
+26% +$153K ﹤0.01% 2059
2026
Q1 		$671K Buy
73,340
+25,269
+53% +$355K ﹤0.01% 1808
2025
Q4 		$769K Buy
48,071
+30,071
+167% +$876K ﹤0.01% 1670
2025
Q3 		$838K Hold
18,000
– – ﹤0.01% 1501
2025
Q2 		$528K Hold
18,000
– – ﹤0.01% 1539
2025
Q1 		$463K Buy
+18,000
New +$443K ﹤0.01% 1505

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Rockefeller Capital Management's LENZ Position: Q2 2026 in Review

Rockefeller Capital Management increased its LENZ Therapeutics (LENZ) stake by 26% in Q2 2026, buying an estimated $153K and bringing the position to 92,350 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #2059.

Rockefeller Capital Management first reported a position in LENZ in Q1 2025 and has held it in 6 quarters since. The position peaked at $838K in Q3 2025. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Rockefeller Capital Management held 92,350 shares of LENZ Therapeutics worth $525K as of Q2 2026.
  • Rockefeller Capital Management bought 19,010 LENZ Therapeutics shares in Q2 2026, an estimated $153K.
  • LENZ Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2059 holding.
  • Rockefeller Capital Management first reported a position in LENZ Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Rockefeller Capital Management's LENZ Therapeutics position peaked at $838K in Q3 2025.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.